Arrowhead Pharmaceuticals, Inc. shines with 19 clinical programs, strategic partnerships, and promising RNAi data. Click for ...

First patient dosed in phase 1b/2a trial for castration-resistant metastatic prostate cancer, evaluating pocenbrodib alone and with other drug combinations.

THIO has gained its generic name and preclinical data on a different form of the cancer drug suggests it could improve ...

The company stated that although it has dropped vobra duo, it remains optimistic about its other candidate MGC026.

Researchers at the University of Tsukuba have investigated the changes in the primary evaluation items in phase II clinical ...

A consortium of Austrian research groups from the University of Vienna, MedUni Vienna and Technikum Wien, together with ...

Discover recent clinical trial failures in depression and explore potential pathways for advancing antidepressant drug ...

Discover why Gyre Therapeutics is rated 'Hold' amid volatile stock behavior, uncertain long-term prospects, and pending Phase ...

For the first time, scientists say, they have evidence that using a biologic drug to remove sticky beta amyloid plaques from the brains<a class="excerpt-read-more" href=" More ...

Pump.Science’s decentralized model aims to reshape scientific funding and support longevity research, but challenges remain.

Reported positive data updates from its ongoing Phase 2a trial of lead program IMM-1-104, including encouraging responses in combination with ...

A pair of privately-held developers of editing-based therapies have some successes to show for their recent efforts to ...